The FDA announced a June advisory committee meeting about COVID vaccines for kids younger than 6. The AMA has updated its billing codes ahead of an expected decision on Moderna s shot in this age group
India has approved emergency use of Biological E s COVID-19 vaccine Corbevax for children aged five to 12 and Bharat Biotech s Covaxin inactivated-virus vaccine for six to 12-year-olds, the country s health minister said on Tuesday.
These students health conditions, which include cancer, cystic fibrosis, asthma, Down syndrome, lung conditions, and weakened immune systems, make them particularly vulnerable to COVID-19.
The Centers for Disease Control and Prevention puts the cumulative number of COVID-19 cases at almost 12.0 million as of March 21, or 17.5% of the nationwide total.